| 中文別名 |
司帕沙星;順-5-氨基-1-環丙基-6,8-二氟一1,4-二氫-7-(3,5-二甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸;5-氨基-1-環丙基-7-(順式-3,5-二甲基-1-哌嗪基)-6,8-二氟-1,4-二氫-4-氧代-3-喹啉羧酸;司氟沙星;蘇柏沙星;司帕沙星溶液;司帕沙星(司氟沙星);普尼拉明;司帕沙星 標準品;5-氨基-1-環丙基-7-(cis-3,5-二甲基-1-哌嗪基)-6,8-二氟-1,4-二氫-4-氧代喹啉-3-羧酸;磷酸丙吡胺;司帕沙星(標準品);司帕沙星溶液,100PPM;司帕沙星溶液, 1000PPM;司帕沙星溶液, 100UG/ML 甲醇溶液;司帕沙星溶液, 1000UG/ML 甲醇溶液 |
質量指標 |
|
| 英文別名 |
Sparfloxacin;5-AMINO-1-CYCLOHEXYL-7-(CIS-3,5-DIMETHYLPIPERAZINO)-6,8-DIFLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLINECARBOXYLIC ACID;at4140;ci978;Clorsulon, Vetranal;3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-, cis-;3-Quinolinecarboxylic acid, 5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-1,4-dihydro-4-oxo-, rel- (9CI);3-QUINOLINECARBOXYLIC ACID, 5-AMINO-1-;5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;5-amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;cis-5-amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid;MMOL, DELIVERED >;Parox;PD 1315-1;Sparcin;Sparfloxaci;SPARFLOXACIN, [2-14C]- 5-25 MCI(185-925 MBQ);SULFAMIC ACID;Zagam;Spara;RP-64206;CP 103826;Sparfloxacinum;Sparfloxacine;Esparfloxacino;CI 978;AT 4140;Sparfloxacine [INN-French];Sparfloxacinum [INN-Latin];SPFX;Esparfloxacino [INN-Spanish];PD 131501;Q90AGA787L;5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydr;cis-5-Amino-1-cyclopropyl-7-(3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid;5-Amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
應用領域 |
|
